Dr. Idelfia A. Marte, MD

  • Safety Harbor, FL
  • Medical oncologist
NPI1629023080PAC ID9436219961
Medicare services, 2024
57,752
Medicare patients, 2024
566
Part D claims, 2024
375
MIPS score, 2024
75
Hospital affiliations
2
Practice address
3231 McMullen Booth Rd, Safety Harbor, FL 34695
Practice phone
Call (727) 734-6950
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

BayCare Mease Countryside Hospital

Hospital · Safety Harbor, Florida

See all 4 affiliations

Find Dr. Marte's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Idelfia A. Marte is a medical oncologist in Safety Harbor, Florida

Dr. Marte practices at BayCare Mease Countryside Hospital in Safety Harbor, Florida, part of BayCare Health System.

Dr. Marte's NPI, 1629023080, was assigned on May 24, 2006. Dr. Marte graduated from Renaissance School of Medicine at Stony Brook University in 1986. Dr. Marte holds Florida license ME61596.

NPI and contact details
Medicare PAC ID
9436219961
NPI enumeration date
May 24, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(727) 734-6950
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
66
Medical school graduation
1986

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Idelfia A. Marte practices at BayCare Mease Countryside Hospital in Safety Harbor, Florida

Dr. Marte's primary practice is BayCare Mease Countryside Hospital, at 3231 McMullen Booth Rd, Safety Harbor, FL 34695 in Pinellas County. The practice phone is (727) 734-6950.

Source: Dmand AI Affiliation Data

Dr. Idelfia A. Marte is affiliated with 3 sites of care and 1 medical group

Dr. Marte's primary practice is BayCare Mease Countryside Hospital in Safety Harbor, Florida, part of BayCare Health System. Dr. Marte is also affiliated with Morton Plant Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Marte to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Marte

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Idelfia A. Marte's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marte practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
BayCare Mease Countryside HospitalAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Marte practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across BayCare Health System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Idelfia A. Marte is one of 477 medical oncologists in Florida

Medical oncology is Dr. Marte's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Marte is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Marte's licenses on file in 2 states: Florida and New York.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME61596 · 1992 to 2026 · taxonomy 207RX0202X
  • New York license1987 to 1992

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Marte treats.

Medical oncologists near Dr. Marte

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Idelfia A. Marte billed Medicare for 57,752 services in 2024

CMS data shows 57,752 Medicare services from Dr. Marte across 33 procedure codes in 2024, for 566 Medicare patients. Medicare paid $281,915 for them.

Medicare services, 202457,752
Medicare patients566
Paid by Medicare$281,915
Procedure codes33

Dr. Marte's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Other services
2023: 55,3502024: 37,77432%
Drugs given in the office
2023: 21,1132024: 13,96934%
Tests and treatments
2023: 2,1552024: 1,80516%
Lab and pathology
2023: 1,7692024: 1,43919%
Office and hospital visits
2023: 1,7842024: 1,42820%
Surgery
2023: 1,5732024: 1,33715%

Where Dr. Marte's Medicare services took place, 2024

  • In an office57,663100%
  • In a facility890%

Dr. Marte compared with the Florida median for medical oncologists, 2024

  • Dr. Marte
  • Florida median
Medicare services
57,752vs 19,7552.9 times
Medicare patients
566vs 541Close to median
Part D claims
212vs 59865% below

Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Marte's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Marte

Need commercial claims for Dr. Marte?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Marte and other medical oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Idelfia A. Marte treated 566 Medicare patients in 2024, average age 77

CMS counts 566 Medicare patients who saw Dr. Marte in 2024. The largest group is 75 to 84, with 239 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marte's median patient age at 70, with 67% women.

Medicare patients, 2024566
Average age77
Average risk score2.28
Also on Medicaid9%

Dr. Marte's Medicare patients by age, 2024

Dr. Marte's Medicare patients by sex, 2024

  • Women37566%
  • Men19134%

Chronic conditions among Dr. Marte's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis55%
  4. Cancer46%
  5. Ischemic heart disease42%
  6. Chronic kidney disease41%
  7. Anxiety36%
  8. Mood disorders33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Marte's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women67%
  • Men31%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Idelfia A. Marte wrote 375 Medicare Part D claims in 2024

In 2024, Dr. Marte wrote 375 Medicare Part D claims for 118 patients. 68% of them were for generic drugs. CMS names the drug for 212 of them, across 10 drugs with 11 or more claims each, at $1,091,678 in total drug cost. In 2023, CMS named 305 claims across 12 drugs.

Part D claims, 2024375
Drugs named by CMS10
Total drug cost$1.1M
Part D patients118

Dr. Marte's Part D claims by kind of drug, 2024

  • Generic255 claims68%
  • Brand-name120 claims32%

Dr. Marte's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Marte's Part D claims, 2024

  • Opioids10%38 of 375 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3052024: 21230%

Drugs named by CMS: 10 in 2024, 12 in 2023.

See all prescribing by Dr. Marte

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Idelfia A. Marte scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Marte for performance year 2024, reported as part of a group. Dr. Marte accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Marte by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Idelfia A. Marte received $26,102 in industry payments from 2016 to 2025

CMS Open Payments shows 662 general payments to Dr. Marte from 63 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Janssen Pharmaceuticals, Inc paid the most, $6,213.

General payments to Dr. Marte by program year, 2016 to 2025

General payments to Dr. Marte by kind, 2016 to 2025

$26.1Kin total
  • Food and beverage$14,92557%
  • Consulting fees$7,62529%
  • Speaker and faculty fees$1,7607%
  • Travel and lodging$1,1534%
  • Education$6392%

Companies that paid Dr. Marte the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Marte

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Idelfia A. Marte graduated from Renaissance School of Medicine at Stony Brook University

Dr. Marte graduated from Renaissance School of Medicine at Stony Brook University in 1986.

  1. Medical schoolRenaissance School of Medicine at Stony Brook University
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Idelfia A. Marte accepts plans from 21 insurance carriers

Dr. Marte is in network with 21 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.

Plan types Dr. Marte accepts, by number of carriers

  1. PPO14
  2. HMO12
  3. Medicare10
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Idelfia A. Marte's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Idelfia A. Marte

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Idelfia A. Marte's NPI number?

Dr. Idelfia A. Marte's NPI number is 1629023080. It was assigned on May 24, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Idelfia A. Marte?

Dr. Idelfia A. Marte is a medical oncologist in Safety Harbor, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Idelfia A. Marte practice?

Dr. Marte practices at 3231 McMullen Booth Rd, Safety Harbor, FL 34695. Dr. Marte's primary practice is BayCare Mease Countryside Hospital in Safety Harbor, Florida, part of BayCare Health System. Dmand AI also links Dr. Marte to 1 group practice or clinic.

What is Dr. Idelfia A. Marte's office phone number?

The practice phone on file for Dr. Marte is (727) 734-6950.

What is Dr. Idelfia A. Marte's medical license number?

Dr. Marte holds Florida license ME61596, one of the licenses on file in 2 states.

Which states has Dr. Idelfia A. Marte been licensed in?

Dmand AI has state licenses on file for Dr. Marte in Florida (1992 to 2026) and New York (1987 to 1992).

Which hospitals is Dr. Idelfia A. Marte affiliated with?

Dr. Marte practices at BayCare Mease Countryside Hospital in Safety Harbor, Florida. Dr. Marte is also affiliated with Morton Plant Hospital.

What medical group is Dr. Idelfia A. Marte part of?

Dr. Marte is linked to Florida Cancer Specialists & Research Institute.

Does Dr. Idelfia A. Marte accept Medicare?

Yes. CMS data shows Dr. Marte billed Medicare for 57,752 services in 2024, and Dr. Marte accepts Medicare assignment.

What is Dr. Idelfia A. Marte's MIPS score?

Dr. Marte's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Idelfia A. Marte see?

CMS counts 566 Medicare patients who saw Dr. Marte in 2024, with an average age of 77.

Is Dr. Idelfia A. Marte board certified?

Yes. Dr. Marte is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Idelfia A. Marte bill to Medicare?

In 2024, Dr. Marte's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J1756) and injected or infused drug (J0897).

Where did Dr. Idelfia A. Marte go to medical school?

Dr. Marte graduated from Renaissance School of Medicine at Stony Brook University in 1986.

What drugs does Dr. Idelfia A. Marte prescribe most?

In 2024 Medicare Part D data, Dr. Marte's most prescribed drugs by claims were Anastrozole, Revlimid and Oxycodone HCl.

Has Dr. Idelfia A. Marte received payments from drug or device companies?

CMS Open Payments shows $26,102 in general payments to Dr. Marte from 63 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Idelfia A. Marte been practicing?

Dr. Marte graduated from medical school in 1986, 40 years ago.

What insurance does Dr. Idelfia A. Marte accept?

Dr. Marte is in network with 21 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)